ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2022年02月04日 11時00分
Source:
Eisai
エーザイ、人事異動を発表
東京, 2022年02月04日 - (JCN Newswire) - エーザイはこのたび、人事異動（2022年2月3日付 執行役人事異動）を以下のとおり発表しました。
2022年2月3日付 執行役人事異動
新任務／旧任務／氏名
メディスン開発センター長（兼）AD申請登録 日本・アジア管轄（執行役）／メディスン開発センター長（執行役）／中濱 明子
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2022/news202212.html
概要：エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: 金融, バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Mitsubishi Power Advances Bahrain's Industrial Growth with Completion of Alba's Power Station 5 Block 4 Combined Cycle Power Plant Project
Feb 19, 2025 16:54 JST
Honda Reveals Specification for its Next-generation Fuel Cell Module
Feb 19, 2025 11:07 JST
NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms
Feb 19, 2025 09:08 JST
Osaka Gas and MHI Launch CO2NNEX Digital Platform for Management and Transfer of Clean Gas Certificates for e-Methane, for Use during Expo 2025
Feb 18, 2025 13:18 JST
TOYOTA GAZOO Racing starts WEC season with Qatar challenge
Feb 17, 2025 18:45 JST
FLAT OUT IN TOKYO "Red Bull Showrun x Powered by Honda" April 2 (Wed)
Feb 17, 2025 16:21 JST
Thrilling TOYOTA GAZOO Racing one-two on Swedish snow
Feb 17, 2025 14:23 JST
Launch of Joint Demonstration Experiment of Remote Provision of GPU Computing Power
Feb 17, 2025 14:10 JST
Mazda to Strengthen Production and Sales Systems in Thailand
Feb 14, 2025 17:04 JST
Toyota Develops New Fuel Cell System
Feb 14, 2025 15:27 JST
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease
Feb 14, 2025 12:09 JST
Nissan, Honda and Mitsubishi Motors terminate MOU regarding consideration of tripartite collaboration
Feb 13, 2025 16:20 JST
ANA InterContinental Tokyo unveils Icon Reborn transformation
Feb 13, 2025 15:00 JST
MHI Thermal Systems Receives Top Honors on Australia's Foremost Consumer Review Platform for Two Series of Split System Air-Conditioners
Feb 13, 2025 12:47 JST
Honda Presents World Premiere of Seven Refreshed Large-size Outboard Motors at the Miami International Boat Show 2025
Feb 13, 2025 10:50 JST
Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management
Feb 13, 2025 10:01 JST
ULVAC Develops Roll-to-Roll Lithium Deposition System, Unveiling at Battery Japan
Feb 13, 2025 08:30 JST
Mitsubishi Power Secures Major Gas Turbine and Services Order for Al Wahda Open Cycle Gas Turbine Power Plant in Morocco
Feb 12, 2025 16:21 JST
MHI Delivers Final 7000-Series AGT Trainset for the Astram Line
Feb 12, 2025 12:24 JST
Fujitsu and Yokohama National University achieve world's first real-time prediction of tornadoes associated with typhoons using supercomputer Fugaku
Feb 12, 2025 11:37 JST
More Latest Release >>
Related Release
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease
2/14/2025 12:09:00 PM JST
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies
2/3/2025 5:23:00 PM JST
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/28/2025 9:46:00 AM JST
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company
1/22/2025 5:18:00 PM JST
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/15/2025 10:03:00 AM JST
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease
1/7/2025 9:14:00 AM JST
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
12/23/2024 5:22:00 PM JST
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
12/11/2024 2:45:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
12/5/2024 11:22:00 AM JST
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea
11/28/2024 4:26:00 PM JST
More Press release >>